An Efficacy and Safety Study of PENTASA in Chinese Patients With Left-sided Active Ulcerative Colitis Followed by a 24-Week Open-Label Extension Phase
Clinical trial NCT02368717 · COMPLETED
Trial details
- NCT number
- NCT02368717
- Sponsor
- Ferring Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-03-01
- Primary completion
- 2017-01-05
- Enrollment
- 281
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.